Main description:

Prevention and treatment of cardiometabolic disorders by lifestyle management is the most understood and effective applications of this emerging field. The focus of this book on prediabetes, diabetes and cardiometabolic diseases is timely and will be a welcome addition to clinicians who wish to gain more knowledge and competence in the area.

This book will focus on the metabolic syndrome, which is the largest non-communicable disease of our time, and lifestyle approaches that drastically reduce the risks and adverse effects of this condition.

Presents a detailed review of clinical evidence and guide for implementation.

Provides a toolkit to counter both the high cost of medications and the need to address metabolic disorders associated with insulin resistance early, before or simultaneous to when medications are indicated.

Contents:

Chapters

1. Epidemiology, Drivers, Public Health Challenges of Prediabetes, Diabetes and Cardiometabolic disease

2. The Evolutionary Biology and Human History of Cardiometabolic Disease

3. The role of cardiac energetics in Cardiometabolic-Based Chronic Disease

4. Endocrine Disrupting Chemicals

5. The Primordial Prevention of Cardiometabolic Risk Factors using Lifestyle Medicine - Implementing Early Childhood Health Promotion

6. Primary Prevention of Type 2 diabetes and Cardiometabolic-Based Chronic Disease Using Lifestyle Medicine

7. Secondary Prevention Example: Using Lifestyle Medicine in Patients with T2D

8. Tertiary Prevention using Lifestyle Medicine for Cardiometabolic-Based Chronic Disease

9. The Mediterranean Diet

10. Vegan Diets for Diabetes Prevention and Management of Cardiometabolic Risk

11. Physical Activity

12. Psychological Stress, Behavioral Modification and Cardiometabolic Health

13. Sleep Hygiene

14. Transculturalizing Lifestyle Medicine for Managing Cardiometabolic-Based Chronic Disease (adjusted)

15. Socioeconomics and Infrastructure

16. Synthesis and Core Recommendations for the use of Lifestyle Medicine to Reduce Dysglycemia and Cardiometabolic Risk